Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Exploring the Efficacy, Safety, and Tolerability of Natalizumab (BG00002) as Adjunctive Therapy in Adult Subjects With Drug-Resistant Focal Epilepsy

  • Beach, Robert (PI)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date05/21/18 → 12/31/21

Funding

  • Biogen IDEC: $133,136.00